Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Surg Oncol. 2017 Nov 28;117(4):756–764. doi: 10.1002/jso.24923

Table 3.

Margin control predictor of survival

Negative Margin Positive Margin
OR (95% CI) P value OR (95% CI) P value
Age
 < 65 1 [Reference] 1 [Reference]
 > 65 1.88 (1.51–2.32) <0.001 1.66(1.26–2.18) <0.001
T Stage
 T1 1 [Reference] 1 [Reference]
 T2 1.16 (0.83–1.62) 0.39 1.65 (0.96–2.84) 0.07
 T3 1.58 (1.14–2.20) 0.006 2.72 (1.69–4.36) <0.001
 T4a 2.13 (1.59–2.84) <0.001 2.85 (1.87–4.35) <0.001
 T4b 3.52 (2.31–5.39) <0.001 3.61 (2.18–5.95) <0.001
N stage
 N0 1 [Reference] 1 [Reference]
 N1–N3 2.47 (1.74–3.51) <0.001 2.41 (1.61–3.58) <0.001
Charlson-Deyo Comorbidity Count
 0 1 [Reference] 1 [Reference]
 1 1.16 (0.87–1.55) 0.31 1.23 (0.87–1.73) 0.87
 > 2 1.63 (1.05–2.53) 0.03 1.06 (0.62–1.80) 0.62
Therapy
 Surgery alone 1 [Reference] 1 [Reference]
 Adj RT* 0.80 (0.63–1.02) 0.07 0.48 (0.35–0.68) <0.001
 Adj CRT* 0.93 (0.66–1.30) 0.66 0.44 (0.30–0.65) <0.001
*

OR- Odds Ratio; CI- Confidence Interval; Adj RT-Adjuvant Radiation Therapy; Adj CRT- Adjuvant Chemoradiation Therapy